EFFECT OF THYROID-FUNCTION ON CONCENTRATIONS OF LIPOPROTEIN(A)

被引:0
作者
ENGLER, H [1 ]
RIESEN, WF [1 ]
机构
[1] ST HOSP ST GALLEN,INST CLIN CHEM & HEMATOL,CH-9007 ST GALLEN,SWITZERLAND
关键词
CHOLESTEROL; LIPOPROTEINS; APOLIPOPROTEINS; HYPERTHYROIDISM; HYPOTHYROIDISM; LIPOPROTEIN RECEPTOR;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The effect of thyroid hormones on concentrations of lipoprotein(a) [Lp(a)l was analyzed in 60 patients with active thyroid dysfunction (hyperthyroidism 30 cases, hypothyroidism 32 cases, and 2 cases with opposite changes) and after normalization of the thyroid state. Treatment of hyperthyroidism increased the mean Lp(a) concentrations by 60% (from 73 to 102 mg/L, P<0.002); at the same time, low-density lipoprotein cholesterol (LDL-C) increased by 53% (from 2.6 to 3.7 mmol/L, P<0.0001) and apolipoprotein B (ape B) by 35% (from 0.91 to 1.17 g/L, P<0.0005). In hypothyroidism, the opposite changes were observed: mean Lp(a) decreased from 136 to 114 mg/L (10%, P<0.02), LDL-C from 4.6 to 3.9 mmol/L (13%, P<0.01), and apo B from 1.51 to 1.20 g/L (14%, P<0.01). Although the changes in Lp(a) concentrations did correlate with changes of LDL-C during treatment of hyperthyroidism (r=0.43, P<0.05), and with changes in apo B during thyroxine-substitution therapy for hypothyroidism (r=0.46, P<0.05), we observed no associations between Lp(a) and LDL-C or apo B in the euthyroid state. These data cannot rule out the possibility that the thyroid hormone-induced increase in LDL-C receptor activity was responsible for the decreased concentrations of Lp(a) in hyperthyroidism. Given that LDL-C is similar to 30% of the Lp(a) molecule but the changes in Lp(a) concentrations are comparable with those in LDL-C (60% vs 53%), and given that Lp(a) is metabolized by an LDLC-receptor-independent pathway, the present data suggest a direct effect of thyroid hormones on Lp(a) synthesis.
引用
收藏
页码:2466 / 2469
页数:4
相关论文
共 25 条
[1]   LIPOPROTEIN AND APOLIPOPROTEIN LEVELS IN SUBCLINICAL HYPOTHYROIDISM - EFFECT OF LEVOTHYROXINE THERAPY [J].
AREM, R ;
PATSCH, W .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (10) :2097-2100
[2]  
Brewer Jr HB, 1990, LIPOPROTEIN A, P211
[3]   HORMONAL-REGULATION OF THE HEPATIC LOW-DENSITY-LIPOPROTEIN RECEPTOR AND THE CATABOLISM OF LOW-DENSITY LIPOPROTEINS - RELATIONSHIP WITH THE SECRETION OF VERY LOW-DENSITY LIPOPROTEINS [J].
BRINDLEY, DN ;
SALTER, AM .
PROGRESS IN LIPID RESEARCH, 1991, 30 (04) :349-360
[4]  
BROWN SA, 1991, J LIPID RES, V32, P1281
[5]  
Dahlen GH., 1990, LIPOPROTEIN A, P151
[6]   APOLIPOPROTEIN-B MESSENGER-RNA EDITING IS MODULATED BY THYROID-HORMONE ANALOGS BUT NOT GROWTH-HORMONE ADMINISTRATION IN THE RAT [J].
DAVIDSON, NO ;
CARLOS, RC ;
LUKASZEWICZ, AM .
MOLECULAR ENDOCRINOLOGY, 1990, 4 (05) :779-785
[7]   LIPOPROTEIN(A) AND APOLIPOPROTEIN-B PLASMA-CONCENTRATIONS IN HYPOTHYROID, EUTHYROID, AND HYPERTHYROID SUBJECTS [J].
DEBRUIN, TWA ;
VANBARLINGEN, H ;
TRIP, MV ;
DEVRIES, ARRV ;
AKVELD, MJ ;
ERKELENS, DW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (01) :121-126
[8]   SERUM LP(A) CONCENTRATIONS ARE UNAFFECTED BY TREATMENT WITH THE HMG-COA REDUCTASE INHIBITOR PRAVASTATIN - RESULTS OF A 2-YEAR INVESTIGATION [J].
FIESELER, HG ;
ARMSTRONG, VW ;
WIELAND, E ;
THIERY, J ;
SCHUTZ, E ;
WALLI, AK ;
SEIDEL, D .
CLINICA CHIMICA ACTA, 1991, 204 (1-3) :291-300
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]  
HOCH FL, 1988, PROG LIPID RES, V27, P169